title: [Vepesid and medroxyprogesterone in the treatment of disseminated malignant melanoma].
authors.forename: M
authors.initials: M
authors.lastname: Pawlicki
authors.forename: J
authors.initials: J
authors.lastname: Rolski
authors.forename: E
authors.initials: E
authors.lastname: Budzanowska
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008297:Male; D008525:Medroxyprogesterone / Q000008:administration & dosage*; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D009367:Neoplasm Staging; D012074:Remission Induction; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D005047:Etoposide; D008525:Medroxyprogesterone
vernacular_title: Vepesid i medroxyprogesteron w leczeniu rozsianego czerniaka złośliwego.